ArticleThe British journal of radiology2017
Ultrasound-guided transcervical radiofrequency ablation for symptomatic uterine adenomyosis.
Article in The British journal of radiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 37 citations in OpenAlex.
- Magnetic resonance-guided focused ultrasound surgery for adenomyosis: current evidence and future directions.Frontiers in medicine · 2026Review
- Conservative Surgical Management of Adenomyosis: Implications for Infertility and Pregnancy Outcomes-A Perspective Review.Journal of clinical medicine · 2025Article
- Successful treatment of large adenomyosis with transcervical radiofrequency ablation in a high-risk patient: A case report and short review.Radiology case reports · 2025Article
- Advances in Adenomyosis Treatment: High-Intensity Focused Ultrasound, Percutaneous Microwave Therapy, and Radiofrequency Ablation.Journal of clinical medicine · 2024Review
- Intrauterine chilled saline instillation reduces endometrial impairment on MRI after ultrasound-guided percutaneous microwave ablation of uterine adenomyosis.Insights into imaging · 2024Article
- Effects of different treatment methods on clinical efficacy and fertility outcomes of patients with adenomyosis.Journal of ovarian research · 2024Article
- An Updated Review of Thermal Ablation Technology for Uterine Fibroids and Adenomyosis: Focusing on Protecting Fertility.International journal of women's health · 2024Review
- Value of contrast-enhanced ultrasonography in microwave ablation treatment of symptomatic focal uterine adenomyosis.Ultrasonography (Seoul, Korea) · 2024Article
- Efficacy and safety of percutaneous microwave ablation for adenomyosis in the posterior uterine wall.The British journal of radiology · 2023Article
- Radiofrequency Ablation for Adenomyosis.Journal of clinical medicine · 2023Review
- Ultrasound-guided microwave ablation for symptomatic adenomyosis: More areas of concern for more uniform and promising outcomes.Journal of interventional medicine · 2022Article
- Long-Term Pregnancy Outcomes of Patients with Diffuse Adenomyosis after Double-Flap Adenomyomectomy.Journal of clinical medicine · 2022Article
- Current and Prospective Treatment of Adenomyosis.Journal of clinical medicine · 2021Review
- A systematic review of outcome reporting and outcome measures in studies investigating uterine-sparing treatment for adenomyosis.Human reproduction open · 2021Review
- Research on pseudo-CT imaging technique based on an ultrasound deformation field with binary mask in radiotherapy.Medicine · 2018Article
- Could Transcervical Radiofrequency Ablation Become a Therapy Option for Focal Adenomyosis?In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo retrospectively evaluate the midterm outcomes of transvaginal ultrasound-guided radiofrequency ablation (RFA) for the treatment of symptomatic uterine adenomyosis.
methods87 patients with symptomatic uterine adenomyosis, who met the inclusion criteria, were enrolled in our study from January 2013 to October 2015. All of the patients underwent transvaginal ultrasound-guided RFA and were followed up for 12 months. Assessment end points included uterus volume reduction rate, lesion regression rate, dysmenorrhoeal score, symptom severity score (SSS) and adverse events.
resultsIn all 87 patients, 81 patients fulfilled the follow-up evaluations post-ablation. The mean uterine volume reduction rate was 35.8% at 1 month, 40.8% at 6 months and 41.2% at 12 months post-ablation. Dysmenorrhoea and SSS statistically significantly declined. Reintervention rate was 18.5%. Two patients developed intrauterine adhesion after ablation. No serious complications including penetration or burn injuries of the nearby organs were observed.
conclusionUltrasound-guided RFA might be a safe and effective minimally invasive alternative in the treatment of symptomatic adenomyosis. Advances in knowledge: This is the first study to evaluate the efficacy and safety of ultrasound-guided RFA for the treatment of adenomyosis to our knowledge. This is also the first study to provide various changes of intrauterine cavity after this treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.